3'-Sulfonylesters of 2,5'-anhydro-1-(2-deoxy-beta-d-threo-pentofuranosyl)thymine as precursors for the synthesis of [(18)F]FLT: syntheses and radiofluorination trials. 2008

Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
Department of Nuclear Medicine and PET Research, Vrije Universiteit Medical Center, De Boelelaan 1085c, Amsterdam, The Netherlands. bwindhorst@rnc.vu.nl

Title compounds [3'-sulfonylesters of 2,5'-anhydro-1-(2-deoxy-beta-d-threo-pentofuranosyl)thymine: 2,5'-anhydro-1-(2-deoxy-3-methanesulfonyl-beta-d-threo-pentofuranosyl)thymine (1a); 2,5'-anhydro-1-(2-deoxy-3-(4-nitrobenzenesulfonyl)-beta-d-threo-pentofuranosyl)thymine (1b); 2,5'-anhydro-1(-2-deoxy-3-(toluenesulfonyl)-beta-d-threo-pentofuranosyl)thymine (1c); and 2,5'-anhydro-1(-2-deoxy-3-(2,2,2-trifluoroethanesulfonyl)-beta-d-threo-pentofuranosyl)thymine 1d] were synthesized, and their use as starting materials for the synthesis of 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) was investigated. Radiofluorination of Compound 1b and subsequent hydrolysis with NaOH, in solution or on solid support, yielded a product with the same retention on radio thin-layer chromatography as [(18)F]FLT. However, careful analysis with high-performance liquid chromatography could not identify the product to be [(18)F]FLT. From several options that were investigated to identify the obtained product, it was shown that fluorination had occurred at the nitro group of the nosylate, and not at the 3'-position. Other sulfonate esters (Compounds 1a, 1c and 1d) did not give any fluorination under any of the investigated reaction conditions. It had to be concluded that title compounds are not suitable as starting materials for the synthesis of [(18)F]FLT under the described conditions.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D000476 Alkanesulfonates Organic esters or salts of sulfonic acid derivatives containing an aliphatic hydrocarbon radical. Alkyl Sulfonates,Sulfonates, Alkyl
D000812 Anhydrides Chemical compounds derived from acids by the elimination of a molecule of water. Anhydride
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
June 1994, Bioorganicheskaia khimiia,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
April 1968, The Journal of organic chemistry,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
April 1975, Journal of medicinal chemistry,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
January 1994, Bioorganicheskaia khimiia,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
September 1995, Bioorganic & medicinal chemistry,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
February 1991, Journal of medicinal chemistry,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
October 1966, The Journal of organic chemistry,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
January 1991, Nucleic acids symposium series,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
February 2003, Nuclear medicine and biology,
Albert D Windhorst, and Pieter J Klein, and Joseph Eisenbarth, and Thomas Oeser, and Perry S Kruijer, and Michael Eisenhut
August 1967, The Journal of organic chemistry,
Copied contents to your clipboard!